Thrive Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Thrive Wealth Management's AMGN Position: Q3 2026 in Review
Thrive Wealth Management reduced its Amgen (AMGN) stake by 16% in Q3 2026, selling an estimated $200K and leaving 2,717 shares worth $1.15M. The position accounts for 0.14% of the portfolio, ranked #76.
Thrive Wealth Management first reported a position in AMGN in Q2 2022 and has held it in 18 quarters since. The position peaked at $1.17M in Q2 2026. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Thrive Wealth Management held 2,717 shares of Amgen worth $1.15M as of Q3 2026.
- Thrive Wealth Management sold 501 Amgen shares in Q3 2026, an estimated $200K.
- Amgen made up 0.14% of Thrive Wealth Management's portfolio in Q3 2026, its #76 holding.
- Thrive Wealth Management first reported a position in Amgen in Q2 2022 and has held it in 18 quarters since.
- Thrive Wealth Management's Amgen position peaked at $1.17M in Q2 2026.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Thrive Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.